Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05011253 · ClinicalTrials.gov registry record · NA
Electronic Triggers: Microhematuria Trigger
A NA study, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 2,000
- Enrollment target
NCT05011253 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 2,000 participants.
The verdict
NCT05011253, a NA study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,000 participants
- Enrollment target
Study Summary
The research team will evaluate the effectiveness of an InBasket Results message that prompts providers to place appropriate follow up orders.
Interventions
- OTHER Electronic Trigger Microhematuria Alert
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,000 participants |
| Start Date | 2021-10-06 |
| Est. Completion | 2022-06-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05011253
The ClinicalTrials.gov registry entry for NCT05011253 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 2,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Electronic Trigger Microhematuria Alert is the first listed.
NCT05011253 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05011253 about?
NCT05011253 is a clinical study titled "Electronic Triggers: Microhematuria Trigger". The research team will evaluate the effectiveness of an InBasket Results message that prompts providers to place appropriate follow up orders.
What is the current status of trial NCT05011253?
This trial is currently completed. It is a NA study. The enrollment target is 2,000 participants. The study started on 2021-10-06. Estimated completion is 2022-06-06.
What interventions are being tested in trial NCT05011253?
The interventions under investigation include: Electronic Trigger Microhematuria Alert (OTHER).
Who is sponsoring clinical trial NCT05011253?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.